RBC raises target for Fisher & Paykel Healthcare stock

Published on 10/01/2026 at 10:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2027 profit guidance is NZD 525 million-565 million. Fisher & Paykel Healthcare stock is NZD 46.45 on October 1, 2026, at its high.

FPH, NZFAPE0001S2, Illustration mit AI erstellt.

RBC Capital upgraded Fisher & Paykel Healthcare stock to Outperform on September 16, 2026, and raised its target from NZD 39.00 to NZD 52.00 from Sector Perform. The move puts valuation and the company's fiscal 2027 outlook at the center of the investment case.

RBC sees wider upside

According to Investing.com on September 16, 2026, RBC cited execution, hospital market growth and further operating leverage. Its NZD 52.00 target is 13.33 percent above the NZD 46.45 primary exchange quote, using the same currency.

The valuation argument is demanding. RBC also described Fisher & Paykel Healthcare as trading at a premium to peers, while pointing to its growth profile and a relatively low PEG ratio among large-cap growth healthcare companies.

Guidance moves higher

Simply Wall St reports that fiscal 2027 operating revenue guidance is NZD 2.47 billion to NZD 2.57 billion, compared with NZD 2.45 billion to NZD 2.57 billion previously. Net profit after tax guidance is NZD 525 million to NZD 565 million, versus NZD 500 million to NZD 550 million previously.

The lower end of the profit range therefore increased by 5.00 percent, while the upper end rose by 2.73 percent. That combination gives the RBC upgrade a measurable earnings anchor, although the unchanged top revenue boundary keeps execution important.

Revenue supports the thesis

Alpha Insights says fiscal 2026 revenue grew 14.20 percent to NZD 2,308.0 million, while operating cash flow reached NZD 661.0 million. The company also generated NZD 466.0 million of free cash flow after NZD 195.0 million of capital expenditure.

On the New Zealand Stock Exchange, Fisher & Paykel Healthcare was last at NZD 46.45 on October 1, 2026 at 5:00 p.m. NZDT. That equals the finance quote's 52-week high of NZD 46.45 and places the stock at a market capitalization of NZD 27.3 billion.